Leishmaniasis (Kala-Azar) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
The Leishmaniasis (Kala-Azar) clinical trial market research report provides an overview and top-line data relating to the clinical trials on Leishmaniasis. The report includes an overview of trials count and their average enrollment in top countries conducted globally. It also includes coverage of disease clinical trials by region and top countries, trial phase, trial status, end points status, and sponsor type. The report also provides prominent drug names and trial counts for in-progress trials (based on the number of ongoing trials).
Leishmaniasis Clinical Trials Market Distribution by Regions and Countries
The top regions in the Leishmaniasis clinical trials market are the Middle East and Africa, Asia Pacific, North America, Europe, and South and Central America. Most of the clinical trials were conducted in the Middle East and Africa.
In the country-wise analysis, Iran has the highest number of kala-azar clinical trials, as of September 2022. Ethiopia has the highest average patient enrollment in Leishmaniasis clinical trials, as of September 2022.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, the United Kingdom has the highest proportion of Leishmaniasis (Kala-Azar) to infectious disease clinical trials as of September 2022.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Brazil have the highest proportion of Leishmaniasis to infectious disease clinical trials as of September 2022.
Leishmaniasis Clinical Trials Market Analysis, By Regions
For more regional insights on Leishmaniasis clinical trials market, download a free report sample
Leishmaniasis Clinical Trials Market Segmentation by Sponsor Types
The key sponsor types in the Leishmaniasis clinical trials market are the institution, company, and government. Out of them, the institution segment dominates the market.
Leishmaniasis Clinical Trials Market Analysis, by Sponsor Types
To know more about key sponsor types in Leishmaniasis clinical trials market, download a free report sample
Competitive Landscape
The leading companies in the Leishmaniasis clinical trials market are Medecins Sans Frontieres, Knight Therapeutics Inc, Wellcome Trust, Lifecare Innovations Pvt Ltd, Aeterna Zentaris Inc, National Institute for Medical Research Development, GSK plc, Exir Nano Sina Co, Dafra Pharma International NV, and Aragen Life Sciences Pvt Ltd. Medecins Sans Frontieres sponsored the highest number of Leishmaniasis clinical trials.
Leishmaniasis Clinical Trials Market Analysis, by Leading Companies
To know more about leading companies in the Leishmaniasis clinical trials market, download a free report sample
Leishmaniasis Clinical Trials Market Report Overview
Key Regions | The Middle East and Africa, Asia Pacific, North America, Europe, and South and Central America |
Key Countries | Iran, India, Brazil, The United States, Bolivia, China, Bangladesh, Colombia, Sudan, and Ethiopia |
Key Sponsor Types | Institution, Company, and the Government |
Leading Companies | Medecins Sans Frontieres, Knight Therapeutics Inc, Wellcome Trust, Lifecare Innovations Pvt Ltd, Aeterna Zentaris Inc, National Institute for Medical Research Development, GSK plc, Exir Nano Sina Co, Dafra Pharma International NV, and Aragen Life Sciences Pvt Ltd |
Scope
The report provides:
- A snapshot of the global clinical trials landscape
- Top level data related to the clinical trials by region, country, trial status, trial phase, sponsor type, and end point status
- Reviews of top companies involved and enlists all trials pertaining to the company
- All the unaccomplished trials with the reason for unaccomplishment
- Enrollment trends for the past five years
- Latest news for the past three months
Reasons to Buy
- Assists in formulating key business strategies with regard to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top-level analysis of the global clinical trials market which helps in identifying key business opportunities
- Supports understanding of trial count and enrollment trends by country in the global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted trials
- Facilitates clinical trial assessment of the indication on a global, regional, and country level
Knight Therapeutics Inc
Wellcome Trust
Lifecare Innovations Pvt Ltd
Aeterna Zentaris Inc
GSK plc
National Institute for Medical Research Development
Aragen Life Sciences Pvt Ltd
Dafra Pharma International NV
Exir Nano Sina Co
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key regions in the Leishmaniasis clinical trials market?
The top regions in the Leishmaniasis clinical trials market are the Middle East and Africa, Asia Pacific, North America, Europe, and South and Central America.
-
What are the key countries in the Leishmaniasis clinical trials market?
The top countries in the Leishmaniasis clinical trials market are Iran, India, Brazil, the United States, Bolivia, China, Bangladesh, Colombia, Sudan, and Ethiopia.
-
What are the key sponsor types in the Leishmaniasis clinical trials market?
Institutions, companies, and the government are the key sponsor types in the Leishmaniasis clinical trials market.
-
Which are the leading companies in the Leishmaniasis clinical trials market?
The leading companies in the Leishmaniasis clinical trials market are Medecins Sans Frontieres, Knight Therapeutics Inc, Wellcome Trust, Lifecare Innovations Pvt Ltd, Aeterna Zentaris Inc, National Institute for Medical Research Development, GSK plc, Exir Nano Sina Co, Dafra Pharma International NV, and Aragen Life Sciences Pvt Ltd.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.